Edwards Lifesciences SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

10-QNov. 4, 2026, 4:24 p.m. ETView on SEC.gov
8-KNov. 4, 2026, 4:21 p.m. ETView on SEC.gov Our explainer
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedEdwards Lifesciences Q3 2026 adjusted EPS of $0.80 beats $0.74 consensus on $1.72 billion sales; raises 2026 sales, TAVR, TMTT and adjusted EPS guidance
4Oct. 8, 2026, 5:24 p.m. ETView on SEC.gov
4Sept. 14, 2026, 6:04 p.m. ETView on SEC.gov
4Sept. 14, 2026, 6:04 p.m. ETView on SEC.gov
4Sept. 11, 2026, 7:15 p.m. ETView on SEC.gov
4Sept. 11, 2026, 7:15 p.m. ETView on SEC.gov
4Aug. 31, 2026, 5:47 p.m. ETView on SEC.gov
4Aug. 28, 2026, 4:32 p.m. ETView on SEC.gov
8-KAug. 28, 2026, 4:15 p.m. ETView on SEC.gov
Departure/appointment of directors or officers
4Aug. 26, 2026, 6:36 p.m. ETView on SEC.gov
4Aug. 26, 2026, 6 p.m. ETView on SEC.gov
4Aug. 11, 2026, 5:07 p.m. ETView on SEC.gov
10-QAug. 4, 2026, 4:14 p.m. ETView on SEC.gov
4July 30, 2026, 5:30 p.m. ETView on SEC.gov
4July 28, 2026, 7:40 p.m. ETView on SEC.gov
4July 27, 2026, 6:59 p.m. ETView on SEC.gov